Totalbanken A/S og Sparekassen Danmark ønsker at fusionere
Bestyrelserne i Totalbanken A/S og Sparekassen Danmark har dags dato indgået en aftale om at søge en fusion mellem de to pengeinstitutter med Sparekassen som det fortsættende pengeinstitut og under navnet Sparekassen Danmark.
Hensigten med fusionen er at skabe et større og stærkere pengeinstitut, og samtidig give Sparekassen Danmark et godt udgangspunkt for ekspansion på Fyn. Det fusionerede pengeinstitut vil få ca. 330.000 kunder, ca. 90.000 garanter samt ca. 1.325 medarbejdere. Instituttet vil have en balance på ca. 65 mia. kroner. Det fusionerede pengeinstitut vil have over 60 kundevendte afdelinger heraf 4 på Fyn. Der vil ikke blive afskediget medarbejdere som følge af fusionen.
De fire største aktionærer i Totalbanken ejer tilsammen 57,5 % af aktierne i Totalbanken, og de har alle afgivet forhåndstilsagn om at ville stemme for fusionen.
Aktionærerne i Totalbanken modtager som vederlag ved fusionen DKK 233 i garantkapital i Sparekassen Danmark for hver aktie á nominelt DKK 20 i Totalbanken. Aktionærerne i Totalbanken vil forud for den ekstraordinære generalforsamling, hvor der skal stemmes om fusionsforslaget, få fremsendt skriftligt informationsmateriale om fusionen og konsekvenserne af ombytningen fra aktiekapital i Totalbanken til garantkapital i Sparekassen Danmark.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Conqueror Freight Network brings together more than 120 logistics leaders from all over the world in Bali to celebrate its 10th Annual Meeting2.5.2024 14:08:15 CEST | Press release
Conqueror seized this special anniversary as an opportunity to recognize founding members with an Awards Ceremony and to present its new web app, its new website and cutting-edge digital services Bali, 2nd May 2024: Conqueror’s networking and conference event, from the 21st to the 23rd of April, came to a successful close last Wednesday. Conqueror Freight Network hosted professional leaders from the freight forwarding industry to discuss the global logistics environment, the industry challenges and growth and the technological trends in freight forwarding. The meeting that took place at the Intercontinental Bali Resort in Bali, Indonesia was attended by more than 120 freight forwarders from over 60 countries, facilitating their company’s increase, expansion and networking. In order to mark the 10th edition of Conqueror’s in-person conference, they presented an award honoring longstanding members who have been integral to the network since its inception, making invaluable contributions
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism2.5.2024 14:00:00 CEST | Press release
Designation reflects the seriousness of the disease and the potential for eneboparatide to address the urgent need for new treatment options that address key treatment goals in hypoparathyroidism LYON, France and CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that eneboparatide, its lead therapeutic peptide candidate in Phase 3 development for the treatment of hypoparathyroidism, has been granted fast track designation by the U.S. Food and Drug Administration (FDA). The FDA’s Fast Track process is designed to facilitate the development and expedite the review of new drugs to treat serious conditions with unmet medical needs, with the goal of introducing new treatment options to patients faster. “We believe FDA’s granting of fast track designation to eneboparatide reflects the agency’s recognition of the significant unmet needs that persist among pa
Subsea7: Subsea Integration Alliance collaboration agreement with Equinor; Commencing work on Wisting and Bay du Nord2.5.2024 13:57:46 CEST | Press release
Luxembourg – 2 May 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the signing of a new long-term strategic collaboration agreement between Equinor and Subsea Integration Alliance (which comprises Subsea7 and OneSubsea). The agreement, which was signed today in Stavanger, Norway, represents an innovative, integrated way of working. It enables early information sharing and other collaborative benefits critical to unlocking subsea projects by making them economically viable. Building on their experience as members of Subsea Integration Alliance, this agreement also further cements Subsea7 and OneSubsea’s positions as trusted contractors to Equinor. The agreement paves the way for exclusive collaboration to begin immediately on early, joint concept studies for two projects: the Wisting field offshore Norway, and Bay du Nord, off Newfoundland and Labrador, Canada. Under the agreement, any resulting EPCI scopes would be directly awarded to the Alliance if a final investme
Avance Gas Holding Ltd: Invitation to Earnings Presentation for the First Quarter of 20242.5.2024 13:49:10 CEST | Press release
Bermuda, May 2, 2024, Avance Gas Holding Ltd. (ticker "AGAS") will on Wednesday May 15, 2024, release its unaudited results for the first quarter of 2024. In connection with the earnings release, an audio webcast and conference call will be held at 14:00 (CEST). The presentation and webcast link will be available from the Investor Relation section at Avance Gas' website www.avancegas.com prior the presentation and available by using the following links: Webcast: https://edge.media-server.com/mmc/p/qwb4tssb Conference call: https://register.vevent.com/register/BI12e2e54dc1ed4c3caea0e446cbd38c35 A Q&A session will be held after the conference call/webcast. For further queries: please contact: Randi Navdal Bekkelund, CFO Telephone: +47 23 11 40 00 Email: IR@avancegas.com ABOUT AVANCE GAS Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carriers (VLGCs) and owns six
Oma Savings Bank Plc: Manager´s Transactions – Jarmo Salmi2.5.2024 13:30:00 CEST | Press release
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 2 MAY 2024 14.30 P.M. EET, MANAGER’S TRANSACTION Oma Savings Bank Plc: Manager´s Transactions – Jarmo Salmi Person subject to the notification requirements: Name: Jarmo Salmi Position: Member of the Board/Deputy Member Issuer: Oma Savings Bank Plc LEI: 743700LE1ECAPXC5UT18 Notification type: INITIAL NOTIFICATION Reference number: 60910/5/4 Transaction date: 2024-05-02 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: ACQUISITION Instrument type: SHARE ISIN: FI4000306733 Transaction details (1): Volume: 24 Unit price: 17.12 EUR (2): Volume: 176 Unit price: 17.14 EUR Aggregated transactions (1): Volume: 200 Volume weighted average price: 17.1376 EUR Oma Savings Bank Plc Further enquiries: Minna Sillanpää, CCO, tel. +358 50 66592 Distribution: Nasdaq Helsinki Ltd Major media www.omasp.fi OmaSp is the fastest growing in the Nordic countries and Finland’s most profitable bank. About 500 professionals provide nationwide services throug